Affordability Boards: The States’ New Fix for Drug Pricing
381 New England Journal of Medicine 1301, DOI: 10.1056/NEJMp1906010 (Oct. 3, 2019)
Posted: 9 Oct 2019
Date Written: October 3, 2019
Abstract
A new Maryland law that creates a prescription-drug affordability board to help the state regulate drug prices may be a harbinger of what’s to come in drug-pricing legislation. The law permits cost reviews when drug prices or price increases exceed specified thresholds. Establishing affordability boards may be a natural next step that more states take to exert a stronger influence over price spikes and still survive legal challenges.
Keywords: prescription drug crisis, price regulation, health care regulation
Suggested Citation: Suggested Citation
Tara Sklar (Contact Author)
University of Arizona - James E. Rogers College of Law ( email )
P.O. Box 210176
Tucson, AZ 85721-0176
United States